Metabolic Dysfunction-associated Steatotic Liver Disease
📧 Sign up to get email alerts when something new happens for Metabolic Dysfunction-associated Steatotic Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Digital Pathology and AI for Liver Outcomes in MASLD
A completed clinical trial sponsored by PharmaNest evaluated digital pathology and AI for liver outcomes in MASLD. The study explored how di…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Developing Microbial Therapy for MASLD: From Mechanism to Clinical Validation [Phase 1]
Phase 1 clinical trial is evaluating a microbial therapy for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Recruitment i…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Prevalence and Risk Factors of Metabolic-Associated Hepatic Steatosis in Individuals Living With Type 1 Diabetes
This clinical trial update outlines a study to determine how common MASLD is and what risk factors are associated with metabolic-associated …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: MPV as a Predictor for ACS in Patients With MASLD
A clinical trial update describes a study evaluating whether mean platelet volume (MPV) can predict acute coronary syndromes in patients wit…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Large Language Model-based Chatbot for Alcohol Reduction in Patients With Metabolic Alcohol-Related Liver Disease [NA]
Ongoing clinical trial evaluating a large language model–based chatbot to reduce alcohol use in patients with metabolic liver disease, with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Digital Pathology and AI for Liver Outcomes in MASLD (DPAILO-2)
The MASLD DPAILO-2 trial evaluating digital pathology and AI for liver outcomes has completed.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study) [Phase 2]
Phase 2 clinical trial evaluating tesamorelin to reduce liver fat in adults with metabolic steatotic liver disease and related conditions. T…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Structured Physical Activity Intervention in Patients With MASLD Receiving a Mediterranean Diet [NA]
A completed clinical trial evaluating a structured physical activity intervention in patients with MASLD who are receiving a Mediterranean d…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: The Effect of the DASH Diet on Clinical and Metabolic Parameters in Children With MASLD [NA]
Clinical trial assessing the effects of the DASH diet on clinical and metabolic parameters in children with MASLD. Sponsored by Antalya Trai…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Expanded Studies on the SCAPIS Stockholm Reexamination Cohort
This clinical trial update indicates expanded studies for the SCAPIS Stockholm Reexamination Cohort sponsored by Danderyd Hospital, covering…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Multi-country, Cross-sectional Quantitative Study Exploring Awareness, Understanding, and Perceptions of the Relation Between Cardiorenal Metabolic Conditions and MASLD/MASH Among Healthcare Providers, People With MASLD/MASH, and At-risk Population
A completed multi-country cross-sectional study assessing awareness, understanding, and perceptions of the relationship between cardiorenal …
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Exercise for an Aging Liver (EXALIVER) [NA]
EXALIVER is a clinical trial evaluating exercise as an intervention for MASLD and MASH-related liver disease, with the study currently not y…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: SMART Diets for MASLD [Phase 2]
Phase 2 clinical trial update for SMART Diets targeting metabolic dysfunction-associated steatotic liver disease (MASLD); the study is not y…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Prevalence of Obesity in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
A registry entry describes a study on the prevalence of obesity in metabolic dysfunction-associated steatotic liver disease (MASLD), includi…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Testing a Multilevel, Culturally Appropriate Lifestyle Intervention For Hispanic Patients With Metabolic Dysfunction-associated Steatotic Liver Disease [NA]
The trial update indicates enrollment by invitation for a multilevel, culturally appropriate lifestyle intervention for Hispanic patients wi…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: The Establishment of Hong Kong Diabetes Steatotic Liver Disease Register
This clinical trial registry update announces the establishment of a Hong Kong register for metabolic dysfunction-associated steatotic liver…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Spleen Stiffness Measurement for the Detection of Advanced Fibrosis
Clinical trial update for a recruiting study evaluating spleen stiffness measurement as a noninvasive approach to detect advanced fibrosis i…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Study on Risk Factors and Prognosis of MASLD
A completed clinical trial investigating risk factors and prognosis for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is …
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Using Digital Twin Technology and Clinical Decision Support Systems to Improve the Early Detection, Personalised Treatment, and Long-term Monitoring of Patients Across the Full Spectrum of Metabolic-associated Fatty Liver Disease (MAFLD).
A clinical trial update describes a study using digital twin technology and clinical decision support to improve early detection, personaliz…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH [Phase 1, Phase 2]
A completed phase 1/2 clinical trial sponsored by Chuncheon Sacred Heart Hospital evaluated the effects of probiotic strains Pediococcus pen…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: EVOO and Metabolic Liver Health in MASLD [NA]
This update describes a clinical trial investigating the effect of extra virgin olive oil on metabolic liver health in MASLD patients who ar…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Integrating Hepatological, Nutritional, and Psychological Support as a Multidisciplinary Management to Improve Long-term Clinical Outcomes in MASLD [NA]
A completed clinical trial evaluated a multidisciplinary management approach combining hepatology, nutrition, and psychology to improve long…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis) [Phase 3]
A Phase 3 trial (ENLIGHTEN-Fibrosis) is ongoing to evaluate the efficacy and safety of Pegozafermin in participants with metabolic dysfuncti…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Evaluation of Miricorilant on Liver Fat in Patients With MASLD [Phase 1]
Phase 1 clinical trial evaluating Miricorilant on liver fat in patients with MASLD, including NASH and related conditions; currently recruit…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver. [NA]
A clinical trial update from Université de Sherbrooke indicates recruitment for a study testing niacin to stimulate fat storage in adipose t…